Open AccessResults of a Survey on Diagnostic Procedures and Treatment Choices for Neuromyelitis Optica Spectrum Disorder in Korea: Beyond the Context of Current Clinical Guidelines
Author(s) -
Hye Lim Lee,
SuHyun Kim,
Jin Myoung Seok,
Byung Jo Kim,
Ho Jin Kim,
Byoung Joon Kim
Publication year - 2022
Publication title -
journal of clinical neurology/the journal of clinical neurology
Language(s) - English
Resource type - Journals
eISSN - 2005-5013
pISSN - 1738-6586
DOI - 10.3988/jcn.2022.18.2.207
Subject(s) - neuromyelitis optica , medicine , rituximab , spectrum disorder , demyelinating disease , context (archaeology) , demyelinating disorder , pediatrics , multiple sclerosis , disease , psychiatry , immunology , antibody , paleontology , biology
Neuromyelitis optica spectrum disorder (NMOSD) is a rare demyelinating disease of the central nervous system (CNS). We investigated the medical behaviors of experts in Korea when they are diagnosing and treating NMOSD.